More about

Ulcerative Colitis

News
January 24, 2020
2 min read
Save

Mirikizumab improves bowel movement urgency in ulcerative colitis

Mirikizumab improves bowel movement urgency in ulcerative colitis

AUSTIN, Texas — Patients with moderately to severely active ulcerative colitis experienced improvements in bowel movement urgency after receiving mirikizumab, according to research presented at the Crohn’s and Colitis Congress.

News
January 24, 2020
2 min read
Save

Lymphoma remains ‘rare event’ in children with IBD

AUSTIN, Texas — While a small risk for lymphoma exists in children with inflammatory bowel disease, occurrences are relatively rare, according to data presented at the Crohn’s and Colitis Congress.

News
January 24, 2020
3 min read
Save

Patients with IBD ‘without a doubt’ struggle with mental health

AUSTIN, Texas – Knowing the burden of inflammatory bowel disease and the constraints of time with gastroenterologists, advanced practice providers and registered nurses need to step into the role of confidant and referral for patients suffering from the mental burden of IBD, according to a experts and patients at the Crohn’s and Colitis Congress.

News
January 24, 2020
1 min read
Save

Top stories in gastroenterology: Ibsrela improves symptoms of IBS subtype, Remicade best for biologic-naive ulcerative colitis

Top stories in gastroenterology: Ibsrela improves symptoms of IBS subtype, Remicade best for biologic-naive ulcerative colitis

One of the top stories in gastroenterology last week showed that Ibsrela reduced abdominal symptoms like bloating, cramping and fullness in patients with constipation-predominant irritable bowel syndrome.

News
January 21, 2020
1 min read
Save

FDA accepts investigational NDA for ulcerative colitis therapy

FDA accepts investigational NDA for ulcerative colitis therapy

The FDA accepted the investigational new drug application for ABX464 for the treatment of patients with moderate to severe ulcerative colitis, according to the drug’s manufacturer.

News
January 21, 2020
3 min read
Save

Crohn’s & Colitis Congress: Collaboration between physicians, patients ‘critical’

Crohn’s & Colitis Congress: Collaboration between physicians, patients ‘critical’

AUSTIN, Texas — Healio Gastroenterology and Liver Disease will be on-site at the Austin Convention Center starting Thursday as a media partner for the Crohn’s & Colitis Congress, bringing the latest in inflammatory bowel disease news to our daily feed.

News
January 20, 2020
1 min read
Save

Microscopic colitis may increase risk for incident IBD

Patients with microscopic colitis were at increased risk for incident inflammatory bowel disease, according to study results.

News
January 16, 2020
2 min read
Save

Remicade is top among biologic-naive patients with UC

Remicade ranked highest for induction of remission and endoscopic improvement among biologic-naive patients, according to a meta-analysis of treatments for moderately to severely active ulcerative colitis.

News
January 16, 2020
6 min read
Save

Looking Back at 2019’s Top 10, Peer Tested by You

Looking Back at 2019’s Top 10, Peer Tested by You

As we enter the 6th year of Healio Gastroenterology and Liver Disease, it is worth looking back at what made us stand out in 2019: the Peer Tested content from online and print as it fared throughout the year.

News
January 13, 2020
4 min read
Save

Expert raises awareness of misunderstood GI symptoms following Pat Sajak’s health scare

Expert raises awareness of misunderstood GI symptoms following Pat Sajak’s health scare

Tonight, Jan. 13, Pat Sajak is expected to make his permanent return to Wheel of Fortune. The 73-year-old’s hosting schedule had been sporadic recently as he underwent and recovered from surgery for a blocked intestine, according to reporting by The Philadelphia Inquirer.

View more